Long course and prognostic factors of virus-induced cirrhosis of the liver

American Journal of Gastroenterology

Volumn 92, Issue 1, 1997, Pages 66-72

  Gentilini, Paolo ^a   Laffi, Giacomo ^a   La Villa, Giorgio ^a   Romanelli, Roberto Giulio ^a   Buzzelli, Giampiero ^a   Casini Raggi, Vincenzo ^a   Melani, Lorenzo ^a   Mazzanti, Roberto ^a   Riccardi, Donato ^a   Pinzani, Massimo ^a   Zignego, Anna Linda ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; GAMMA GLUTAMYLTRANSFERASE; HEPATITIS ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY; IMMUNOGLOBULIN; PLASMA PROTEIN; VIRUS DNA;

ADULT; AGED; ARTICLE; ASCITES; BLEEDING; DISEASE COURSE; ECHOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; ESOPHAGUS VARICES; FEMALE; GASTROINTESTINAL ENDOSCOPY; HEPATIC ENCEPHALOPATHY; HEPATITIS B; HEPATITIS C; HUMAN; JAUNDICE; LIVER BIOPSY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FUNCTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL;

BILIRUBIN; CARCINOMA, HEPATOCELLULAR; CHRONIC DISEASE; ESOPHAGEAL AND GASTRIC VARICES; FEMALE; FOLLOW-UP STUDIES; GASTROINTESTINAL HEMORRHAGE; HEPATIC ENCEPHALOPATHY; HEPATITIS B; HEPATITIS C; HUMANS; JAUNDICE; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 0031031394     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Boyer JL, Miller DJ. Chronic hepatitis. In: Schiff L, Schiff ER, eds. Diseases of the liver, 6th ed. Philadelphia: JB Lippincott, 1987; 687-723.
2. Powell WJ, Klatskin G. Duration of survival in patients with Laennec's cirrhosis. Am J Med 1968;44:406-20.
3. Orloff MJ, Halazz NA, Lipman CH. The complications of cirrhosis of the liver. Ann Intern Med 1967;60:165-70.
4. Saunders JB, Walters JR, Davies AP, et al. A 20-year prospective study of cirrhosis. Br Med J 1981;282:263-6.
5. Sugimura T, Tsuji Y, Sakamoto M, et al. Long-term prognostic factors of liver cirrhosis in the 1980s. J Gastroenterol Hepatol 1994;9:154-61.
6. Ginès P, Quintero E, Arroyo V, et al. Compensated cirrhosis: Natural history and prognostic factors. Hepatology 1987;7:122-8.
7. D'Amico G, Morabito A, Pagliaro L, et al. The liver study group of "V. Cervello" hospital: Survival and prognostic indicators in compensated and decompensated cirrhosis. Dig Dis Sci 1986;31:468-75.
8. Zoli M, Cordiani MR, Marchesini G, et al. Prognostic indicators in compensated cirrhosis. Am J Gastroenterol 1991;86:1508-13.
9. Realdi G, Fattovich G, Hadziyannis S, et al. Survival and prognostic factors in 366 patients with compensated cirrhosis type B: A multicenter study. J Hepatol 1994;21:656-66.
10. ISTAT Istituto Nazionale di Statistica. Tavole di mortalita' e tavole attuariali della popolazione italiana: Note e relazioni anno 1990. 1993: 16-7.
11. Scheuer PJ. Liver biopsy in the diagnosis of cirrhosis. Gut 1970;11: 275-8.
12. Runyon BA. Spontaneous bacterial peritonitis: An explosion of information. Hepatology 1988;8:171-5.
13. Adams RD, Foley JM. The neurological disorder associated with liver disease. Res Publ Assoc Res Nerv Ment Dis 1953;32:198-237.
14. Trey C, Burnes DG, Saunders SJ. Treatment of hepatic coma by exchange blood trasfusion. N Engl J Med 1966;274:473-81.
15. Sherlock S. Diseases of the liver and biliary system, 9th ed. Oxford: Blackwell Science, 1993.
16. National Diabetes Data Group. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 1979; 28:1039-57.
17. Kaplan GL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-81.
18. Peto R, Pike MC. Conservation of the approximation (O-E)2/E in the log-rank test for survival data on tumor incidence data. Biometrics 1973;29:579-84.
19. Cox DR. Regression models and life-tables. J R Stat Soc B 1972;34: 187-220.
20. Mausner JS, Bahn AK. Epidemiology: An introductory text. Philadelphia: WB Saunders, 1974:126-59.
21. Ratnoff OD, Patek AJ. The natural history of Laennec's cirrhosis of the liver: An analysis of 386 cases. Medicine 1942;21:207-68.
22. Poynard T, Zourabichvili O, Hilpert G, et al. Prognostic value of total serum bilirubin/gamma-glutamyl transpeptidase ratio in cirrhotic patients. Hepatology 1984;4:324-7.
23. Sherlock S, Senewiratne B, Scott A, et al. Complications of diuretic therapy in hepatic cirrhosis. Lancet 1966;i:1049-53.
24. Reynolds TB. Portal hypertension. In: Schiff L, Schiff ER, eds. Diseases of the liver, 6th ed. Philadelphia: JB Lippincott, 1987;875-901.
25. Schomerus H, Hamster W, Blunck H, et al. Latent porto-systemic encephalopathy: I. Nature of cerebral functional defects and fitness to drive. Dig Dis Sci 1981;26:622-30.
26. Langer B, Taylor BR, Mackenzie DR, et al. Further report of a prospective randomized trial comparing distal spleno-renal shunt with end-to-side portacaval shunt. Gastroenterology 1985;88:424-9.
27. Baker LA, Smith C, Liebermann G. The natural history of esophageal varices. Am J Med 1959;26:2228-37.
28. Christensen E, Faverholdt L, Schlichting P, et al. Aspects of the natural history of gastrointestinal bleeding in cirrhosis and the effect of prednisone. Gastroenterology 1981;81:944-52.
29. Burroughs AK, Mezzanotte G, Phillips A, et al. Cirrhotics with variceal hemorrhage: The importance of the time interval between admission and the start of the analysis for survival and rebleeding rates. Hepatology 1989;9:801-7.
30. Conn HO, Atterbury EC. Cirrhosis. In: Schiff L, Schiff ER, eds. Diseases of the liver, 7th ed. Philadelphia: JB Lippincott, 1993;875-934.
31. Gentilini P, Melani L, Riccardi D, et al. Hepatocellular carcinoma and viral cirrhosis. Hepatology 1994;20:764-5.
32. Bruix J, Barrera JM, Calcet X, et al. Prevalence of antibodies to hepatitis C virus in Spanish patients with hepatocellular carcinoma and hepatic cirrhosis. Lancet 1989;ii:1004-6.
33. Smadja C. Hepatocellular carcinoma in cirrhosis. Ann Gastroenterol Hepatol 1989;25:129-31.
34. Martin AM, Tejada MRG, Ruiz AD, et al. Clinical and prognostic aspects of liver cirrhosis: A study of 231 cases. Eur J Gastroenterol Hepatol 1993;5:555-9.
35. Tsukuma H, Hiyama T, Tanaka S, et al. Risk factors for hepatocellular carcinoma among patients with chronic liver disease. N Engl J Med 1993;328:1797-801.
36. Calvet X, Bruix J, Ginès P, et al. Prognostic factors of hepatocellular carcinoma in the West: A multivariate analysis in 206 patients. Hepatology 1990;12:753-60.
37. Oka H, Kurioka K, Kim K, et al. Prospective study of early detection of hepatocellular carcinoma in patients with cirrhosis. Hepatology 1990;12:680-7.